Polaris Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Hold |
36,100
| – | – | 0.08% | 81 |
|
|
2025
Q1 | $1.2M | Sell |
36,100
-22,200
| -38% | -$737K | 0.07% | 76 |
|
|
2024
Q4 | $2.01M | Buy |
58,300
+13,300
| +30% | +$458K | 0.1% | 56 |
|
|
2024
Q3 | $1.8M | Buy |
45,000
+16,500
| +58% | +$660K | 0.09% | 66 |
|
|
2024
Q2 | $860K | Hold |
28,500
| – | – | 0.05% | 83 |
|
|
2024
Q1 | $957K | Hold |
28,500
| – | – | 0.05% | 80 |
|
|
2023
Q4 | $921K | Sell |
28,500
-7,600
| -21% | -$245K | 0.04% | 82 |
|
|
2023
Q3 | $1.18M | Hold |
36,100
| – | – | 0.06% | 70 |
|
|
2023
Q2 | $1.27M | Hold |
36,100
| – | – | 0.05% | 74 |
|
|
2023
Q1 | $1.18M | Buy |
36,100
+4,300
| +14% | +$140K | 0.04% | 75 |
|
|
2022
Q4 | $1.75M | Buy |
31,800
+3,300
| +12% | +$182K | 0.06% | 55 |
|
|
2022
Q3 | $1.26M | Hold |
28,500
| – | – | 0.05% | 63 |
|
|
2022
Q2 | $1.39M | Sell |
28,500
-2,400
| -8% | -$117K | 0.05% | 57 |
|
|
2022
Q1 | $1.5M | Hold |
30,900
| – | – | 0.05% | 62 |
|
|
2021
Q4 | $1.32M | Hold |
30,900
| – | – | 0.04% | 71 |
|
|
2021
Q3 | $1.18M | Hold |
30,900
| – | – | 0.04% | 78 |
|
|
2021
Q2 | $872K | Buy |
+30,900
| New | +$872K | 0.03% | 92 |
|